RecruitingNCT06751537

Effectiveness of the WearME System for COPD Severity and Respiratory Function

Effectiveness of WearME System for FEV1/FVC, Respiration and Activity Biomarkers in COPD Patients


Sponsor

LASARRUS Clinic and Research Center

Enrollment

128 participants

Start Date

May 29, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

This observational study evaluates the effectiveness of the WearME system in monitoring COPD severity and respiratory function by comparing its measurements to standard spirometry, capnography, and other clinical assessments in 128 COPD participants.


Eligibility

Min Age: 21 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a wearable device called WearME to see how well it tracks breathing and lung function in people with COPD (chronic obstructive pulmonary disease) — a lung condition that makes it hard to breathe. **You may be eligible if...** - You are between 21 and 100 years old - You have been diagnosed with COPD (any severity — mild, moderate, severe, or very severe) - You can read and sign consent forms in English or Spanish - You are a current, former, or never-smoker **You may NOT be eligible if...** - You have a skin allergy or skin condition that might interfere with wearing the device - You are currently on a breathing machine (invasive mechanical ventilation) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(2)

Johns Hopkins

Baltimore, Maryland, United States

TidalHealth

Salisbury, Maryland, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06751537


Related Trials